The impact of antibiotic and proton pump inhibitor use at the time of adjuvant platinum-based chemotherapy on survival in patients with endometrial cancerPaulina Haight, Laura Chambers, Quinn Kistenfeger et al.|Gynecologic Oncology|2023Cited by 6
Learning to lead: The evolution of a pilot leadership curriculum for gynecologic oncology fellows at the Ohio State UniversityMonica Levine, David E. Cohn, Vincent Wagner et al.|Gynecologic Oncology Reports|2024Cited by 2
RETRACTED: Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancerCourtney Riedinger, Laura Chambers, David A. Mix Barrington et al.|Gynecologic Oncology|2024Cited by 2
Self-reported medical errors, depression, anxiety, stress and burnout in a large NCI-designated comprehensive cancer center (516)Monica Levine, Monica L. Vetter, Wafa Khadraoui et al.|Gynecologic Oncology|2022Cited by 1
Retraction notice to “Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer” [Gynecologic Oncology 183 (2024) 78–84]Courtney Riedinger, Laura Chambers, David A. Mix Barrington et al.|Gynecologic Oncology|2024Cited by 1